Factors associated with time from diagnostic imaging to first treatment: the CAP-Centre study
| Variation of time interval between diagnostic imaging to first treatment – multivariate analysis | All patients# | Patients with unresected NSCLC¶,+ | ||
| Days (n) | 95% confidence interval | Days (n) | 95% confidence interval | |
| Origin time | 50.7 | 48.2 | (37.9–58.6) | |
| Male | −0.8 | (−5.6–4.1) | 1.1 | (−5.12–7.3) |
| Age ≥65 years | 0.9 | (−3.4–5.3) | 1.4 | (−4.2–7.1) |
| Metastatic disease | −15.8 | (−20.4– −11.2) | −14 | (−20.8– −7.3) |
| NSCLC (as compared to SCLC) | 10.4 | (4.2–16.5) | ||
| Adeno/undifferentiated carcinoma (versus squamous cell carcinoma) | 2.5 | (−4.1–9.1) | ||
| Nature of the first healthcare facility | ||||
| Teaching hospital | ref. | |||
| Public hospital | −0.7 | (−7.8–6.4) | ||
| Private hospital | −7.1 | (−12.5– −1.7) | ||
| Administrative department of the first healthcare facility | ||||
| A | 8.7 | (−1.2–18.6) | 9.6 | (−2.1–21.3) |
| B | 2.7 | (−5.7–11.1) | −3.6 | (−14.1–7) |
| C | 14.5 | (3.4–25.7) | 20.3 | (4.4–36.3) |
| D | ref | ref. | ||
| E | 7.6 | (−1.8–17.0) | 4.2 | (−8.4–16.8) |
| F | 10.0 | (4.5–15.5) | 17.5 | (10.6–24.4) |
| Outside CVL region | −5.1 | (−15.0–4.8) | 0.4 | (−15.8–16.6) |
| Nature of the first treatment facility§ | ||||
| Teaching hospital | ref. | |||
| Public hospital | 10.2 | (2.2–18.2) | ||
| Private hospital | 4.3 | (−2.9–11.5) | ||
SCLC: small cell lung cancer; NSCLC: nonsmall cell lung cancer; CVL: Centre-Val de Loire. #: n=520; ¶: n=305; +: excluding patients with histology = “others”, n=37; §: can be different from first healthcare facility.